Convergence Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $914K | Buy |
13,245
+724
| +6% | +$50K | 0.16% | 81 |
|
|
2025
Q1 | $869K | Buy |
12,521
+967
| +8% | +$67.1K | 0.17% | 74 |
|
|
2024
Q4 | $994K | Buy |
11,554
+403
| +4% | +$34.7K | 0.2% | 59 |
|
|
2024
Q3 | $1.33M | Buy |
11,151
+3,243
| +41% | +$386K | 0.28% | 52 |
|
|
2024
Q2 | $1.13M | Buy |
+7,908
| New | +$1.13M | 0.3% | 43 |
|